Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma.

Oncogenesis·2022
Same author

FET fusion oncoproteins interact with BRD4 and SWI/SNF chromatin remodelling complex subtypes in sarcoma.

Molecular oncology·2022
Same author

FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.

EMBO reports·2019
Same author

Requirement for YAP1 signaling in myxoid liposarcoma.

EMBO molecular medicine·2019
Same author

Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma.

Molecular cancer therapeutics·2019

Related Experiment Video

Updated: Apr 30, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

8.5K

DDIT3 Expression in Liposarcoma Development.

Christina Kåbjörn Gustafsson1, Katarina Engström2, Pierre Aman1

  • 1Sahlgrenska Cancer Center, Department of Pathology, Institute of Biomedicine, University of Gothenburg, P.O. Box 425, 40530 Gothenburg, Sweden.

Sarcoma
|May 3, 2014
PubMed
Summary
This summary is machine-generated.

The transcription factor DDIT3 plays a complex role in liposarcoma development. While it promotes liposarcoma morphology, its expression also appears to limit lipoblast and adipocyte formation in these tumors.

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

13.7K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

Related Experiment Videos

Last Updated: Apr 30, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

8.5K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

13.7K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Liposarcomas are mesenchymal tumors with varying adipocyte content.
  • Common types like well-differentiated/dedifferentiated (WDLS/DDLS) and myxoid/round cell (MLS/RCLS) liposarcomas involve DDIT3 expression changes.
  • The precise function of DDIT3 in lipomatous tumors remains elusive.

Purpose of the Study:

  • To investigate the expression patterns of DDIT3 in different liposarcoma subtypes and benign lipomas.
  • To elucidate the role of DDIT3 in lipoblast and adipocyte differentiation within liposarcomas.

Main Methods:

  • Analysis of DDIT3 expression in 37 liposarcoma cases (WDLS/DDLS, MLS/RCLS, PLS) and 11 lipomas.
  • Immunohistochemical assessment of DDIT3-positive cells and correlation with lipoblasts/adipocytes.
  • In vitro adipogenic differentiation assays on DDIT3-expressing cell lines.

Main Results:

  • DDIT3 was highly expressed in major cell subpopulations of WDLS/DDLS and MLS/RCLS, but sparsely in pleomorphic liposarcomas (PLS).
  • Benign lipomas also showed significant DDIT3 expression in large cell subpopulations.
  • No direct correlation was observed between DDIT3-expressing cells and the number of lipoblasts or adipocytes.
  • In vitro studies indicated that DDIT3 induced lipid accumulation in only a subset of cells.

Conclusions:

  • DDIT3 expression is prevalent in common liposarcoma subtypes and benign lipomas.
  • The findings suggest a dual role for DDIT3, potentially promoting liposarcoma development while also limiting adipogenesis.
  • Further research is needed to fully understand DDIT3's complex regulatory function in lipomatous tumor formation.